Pretreatment expression of the perforin gene by circulating CD8(+) T lymphocytes predicts biochemical response to interferon-alpha in patients with chronic hepatitis C
A. Balian et al., Pretreatment expression of the perforin gene by circulating CD8(+) T lymphocytes predicts biochemical response to interferon-alpha in patients with chronic hepatitis C, EUR CYTOKIN, 11(2), 2000, pp. 177-184
It would be of great value to be able to predict, before the initiation of
treatment, which patients with hepatitis C virus-induced chronic hepatitis
will be cured by interferon-alpha (IFN-alpha), Competitive RT-PCR was used
to evaluate spontaneous expression of the perforin gene, a marker of cytoto
xic cell activation, by circulating mononuclear cells in 17 patients underg
oing IFN-alpha treatment, IFN-alpha increased perforin gene expression (p <
0.003), but this was not correlated with outcome. In contrast, pretreatmen
t perforin gene expression levels were higher in the 8 patients with a sust
ained biochemical response after treatment than in the 9 non-responsive pat
ients (p = 0.01). This factor predicted favorable clinical outcome with a s
ensitivity of 75% and a specificity of 89%, Thus, pretreatment immunologica
l status has a major influence on the ability of IFN-alpha to cure chronic
hepatitis C, and the evaluation of perforin gene expression may help to sel
ect patients that will benefit from IFN-alpha treatment.